• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, October 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Antibodies to a retina protein to be used as a kidney cancer marker

Bioengineer by Bioengineer
January 18, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Sechenov University together with their German colleagues suggest a new highly sensitive, quick, and pain-free method for diagnosing kidney cancer.

IMAGE

Credit: Ed Uthman/Wikimedia Commons


Sechenov University together with their German colleagues suggest a new highly sensitive, quick, and pain-free method for diagnosing kidney cancer. This method is based on measuring of the immune response to arrestin-1, a retina protein that is synthesized in the cancerous cells of kidneys.

Tumors can be benign or malignant. The first ones are not extremely dangerous but they can evolve into the latter ones, and those, in turn, are a cause of every sixth death in the world. Around 90-93% of all kidney growths turn out to be malignant, and there are currently no effective methods for early diagnostics. The initial stages of kidney cancer have no signs or specific symptoms, and therefore patients often get diagnosed with kidney cancer when it has already metastasized. At this point, the doctors make prognosis not about the possibility of recovery, but about a patient’s life expectancy.

Cancerous cells are the cells with considerable deviations in their behavior, such as abnormal division, development, or protein synthesis. Proteins may be synthesized in wrong quantities, in a wrong place, or they may be of a poor quality. Normally arrestin-1 is synthesized in the eye retina only, and its occurrence in another body organ may cause intensive autoimmune response (i.e. a reaction against the body’s own proteins). It’s already been discovered that arrestin-1 is present in melanoma (malignant skin tumor). However, the idea to check the kidney tumor cells for this type of protein and to measure the intensity of the immune response to it turned out to be new for the scientific world.

The scientists wanted to find out whether it is possible to use the antibodies to arrestin-1 as well as the protein itself as a marker of cancerous kidney diseases. To do so, they dyed tissue sections, carried out blood tests, and sequenced the samples. The samples for the experiment were collected from patients that suffered from malignant and benign kidney growths. The antibodies to arrestin-1 were found in the blood serum of 75% of the patients; the protein itself was identified in 90% of benign tumors and in over 50% of cancerous ones. Increased levels of arrestin-1 were also noticed in metastasis, especially in the brain metastasis.

All subtypes of kidney tumors synthesize arrestin-1, which makes this method inefficient for differential diagnostics. However, due to its high sensitivity to benign growths, the method helps diagnose a disease on early stages when the chances for recovery are at the highest. The diagnostic procedure is reduced to simple blood test for the antibodies to arrestin-1 instead of a biopsy that is technically complicated and painful for a patient. “The discovery of arrestin-1 synthesis in cases of kidney cancer suggests the possibility of developing anti-cancer vaccines on the basis of this protein in the near future,” says Andrey Zamyatnin, a co-author of the work, and the head of the Institute of Molecular Medicine at Sechenov University.

###

The research was carried out by Sechenov University, a Project 5-100 participant, together with scientists from the Medical and Genetic Scientific Center, Ludwig Maximilian University of Munich, the Belozersky Institute of Physico-Chemical Biology at Lomonosov Moscow State University, the National Medical Research Center of Radiology, and the Institute of Bioorganic Chemistry of the Russian Academy of Sciences.

This research supported by the Russian Science Foundation (RSF) grant 15-15-00100 will be published in the February issue of the Biochimie journal

Media Contact
Nataliya Rusanova
[email protected]

Original Source

https://www.sciencedirect.com/science/article/pii/S0300908418303018?via%3Dihub

Related Journal Article

http://dx.doi.org/10.1016/j.biochi.2018.10.019

Tags: cancerDiagnosticsMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Empowering Older Adults: Shared Decision-Making in Nursing

October 5, 2025

Boosting Malonylation Site Detection with AlphaFold2

October 5, 2025

Assessing Drug Interactions in Neonatal Care Software

October 5, 2025

Unveiling AGC2 Modulators through Advanced Assay Techniques

October 5, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    94 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    92 shares
    Share 37 Tweet 23
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    71 shares
    Share 28 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Empowering Older Adults: Shared Decision-Making in Nursing

Whole Genome Analysis Uncovers Variations in Goat Pigmentation

Boosting Malonylation Site Detection with AlphaFold2

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.